Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer

Details for Australian Patent Application No. 2007338793 (hide)

Owner Amgen Inc.

Inventors Harmange, Jean-Christophe; Choquette, Deborah; Tasker, Andrew; Cheng, Yuan

Agent Shelston IP

Pub. Number AU-B-2007338793

PCT Pub. Number WO2008/079292

Priority 60/876,283 20.12.06 US

Filing date 19 December 2007

Wipo publication date 3 July 2008

Acceptance publication date 3 May 2012

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/4725 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079292 Priority application(s): WO2008/079292

3 May 2012 Application Accepted

  Published as AU-B-2007338793

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338795-Substituted heterocycles and methods of use

2007338792-Substituted heterocycles and methods of use